Literature DB >> 30070769

TGR5 activation induces cytoprotective changes in the heart and improves myocardial adaptability to physiologic, inotropic, and pressure-induced stress in mice.

Zeena Eblimit1, Sundararajah Thevananther2, Saul J Karpen3, Heinrich Taegtmeyer4, David D Moore5, Luciano Adorini6, Daniel J Penny7, Moreshwar S Desai1.   

Abstract

INTRODUCTION: Administration of cholic acid, or its synthetic derivative, 6-alpha-ethyl-23(S)-methylcholic acid (INT-777), activates the membrane GPCR, TGR5, influences whole body metabolism, reduces atherosclerosis, and benefits the cardiovascular physiology in mice. Direct effects of TGR5 agonists, and the role for TGR5, on myocardial cell biology and stress response are unknown.
METHODS: Mice were fed chow supplemented with 0.5% cholic acid (CA) or 0.025% INT-777, a specific TGR5 agonist, or regular chow for 3 weeks. Anthropometric, biochemical, physiologic (electrocardiography and echocardiography), and molecular analysis was performed at baseline. CA and INT-777 fed mice were challenged with acute exercise-induced stress, acute catecholamine-induced stress, and hemodynamic stress induced by transverse aortic constriction (TAC) for a period of 8 weeks. In separate experiments, mice born with constitutive deletion of TGR5 in cardiomyocytes (CM-TGR5del ) were exposed to exercise, inotropic, and TAC-induced stress.
RESULTS: Administration of CA and INT-777 supplemented diets upregulated TGR5 expression and activated Akt, PKA, and ERK1/2 in the heart. CA and INT-777 fed mice showed improved exercise tolerance, improved sensitivity to catecholamine and attenuation in pathologic remodeling of the heart under hemodynamic stress. In contrast, CM-TGR5del showed poor response to exercise and catecholamine challenge as well as higher mortality and signs of accelerated cardiomyopathy under hemodynamic stress.
CONCLUSIONS: Bile acids, specifically TGR5 agonists, induce cytoprotective changes in the heart and improve myocardial response to physiologic, inotropic, and hemodynamic stress in mice. TGR5 plays a critical role in myocardial adaptability, and TGR5 activation may represent a potentially attractive treatment option in heart failure.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  INT-777; TGR5; cholic acid; myocardial adaptation; preconditioning

Mesh:

Substances:

Year:  2018        PMID: 30070769      PMCID: PMC6800140          DOI: 10.1111/1755-5922.12462

Source DB:  PubMed          Journal:  Cardiovasc Ther        ISSN: 1755-5914            Impact factor:   3.023


  52 in total

Review 1.  Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease.

Authors:  I J Benjamin; D R McMillan
Journal:  Circ Res       Date:  1998-07-27       Impact factor: 17.367

2.  Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2014-01-21       Impact factor: 29.690

Review 3.  Mitochondrial proteins in hypertrophy and atrophy: a transcript analysis in rat heart.

Authors:  Heinrich Taegtmeyer; Peter Razeghi; Martin E Young
Journal:  Clin Exp Pharmacol Physiol       Date:  2002-04       Impact factor: 2.557

Review 4.  Endocrine functions of bile acids.

Authors:  Sander M Houten; Mitsuhiro Watanabe; Johan Auwerx
Journal:  EMBO J       Date:  2006-03-16       Impact factor: 11.598

Review 5.  Bile acids as regulatory molecules.

Authors:  Phillip B Hylemon; Huiping Zhou; William M Pandak; Shunlin Ren; Gregorio Gil; Paul Dent
Journal:  J Lipid Res       Date:  2009-04-03       Impact factor: 5.922

6.  Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies.

Authors:  Hiroyuki Sato; Antonio Macchiarulo; Charles Thomas; Antimo Gioiello; Mizuho Une; Alan F Hofmann; Régis Saladin; Kristina Schoonjans; Roberto Pellicciari; Johan Auwerx
Journal:  J Med Chem       Date:  2008-02-29       Impact factor: 7.446

7.  A G protein-coupled receptor responsive to bile acids.

Authors:  Yuji Kawamata; Ryo Fujii; Masaki Hosoya; Masataka Harada; Hiromi Yoshida; Masanori Miwa; Shoji Fukusumi; Yugo Habata; Takashi Itoh; Yasushi Shintani; Shuji Hinuma; Yukio Fujisawa; Masahiko Fujino
Journal:  J Biol Chem       Date:  2003-01-10       Impact factor: 5.157

Review 8.  TGR5 in inflammation and cardiovascular disease.

Authors:  Thijs W H Pols
Journal:  Biochem Soc Trans       Date:  2014-04       Impact factor: 5.407

Review 9.  Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.

Authors:  Derek J Hausenloy; Derek M Yellon
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

10.  Endotoxin leads to rapid subcellular re-localization of hepatic RXRalpha: A novel mechanism for reduced hepatic gene expression in inflammation.

Authors:  Romi Ghose; Tracy L Zimmerman; Sundararajah Thevananther; Saul J Karpen
Journal:  Nucl Recept       Date:  2004-08-16
View more
  16 in total

Review 1.  The gut microbiome and heart failure: A better gut for a better heart.

Authors:  Maxime Branchereau; Rémy Burcelin; Christophe Heymes
Journal:  Rev Endocr Metab Disord       Date:  2019-12       Impact factor: 6.514

Review 2.  Bile acids and salt-sensitive hypertension: a role of the gut-liver axis.

Authors:  Jeanne A Ishimwe; Thanvi Dola; Lale A Ertuglu; Annet Kirabo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-03-04       Impact factor: 4.733

3.  Alterations in gut microbiota and metabolites associated with altitude-induced cardiac hypertrophy in rats during hypobaric hypoxia challenge.

Authors:  Zhiyuan Pan; Yichen Hu; Zongyu Huang; Ni Han; Yan Li; Xiaomei Zhuang; Jiye Yin; Hui Peng; Quansheng Gao; Wenpeng Zhang; Yong Huang; Yujun Cui; Yujing Bi; Zhenjiang Zech Xu; Ruifu Yang
Journal:  Sci China Life Sci       Date:  2022-03-14       Impact factor: 10.372

4.  Restructuring the Gut Microbiota by Intermittent Fasting Lowers Blood Pressure.

Authors:  Huanan Shi; Bojun Zhang; Taylor Abo-Hamzy; James W Nelson; Chandra Shekar R Ambati; Joseph F Petrosino; Robert M Bryan; David J Durgan
Journal:  Circ Res       Date:  2021-02-18       Impact factor: 17.367

Review 5.  Parenteral Nutrition and Cardiotoxicity.

Authors:  Johan van Nispen; Marcus Voigt; Eric Song; Austin Armstrong; Margarita Fedorova; Vidul Murali; Joseph Krebs; Ashish Samaddar; Chandrashekhara Manithody; Ajay Jain
Journal:  Cardiovasc Toxicol       Date:  2021-02-07       Impact factor: 3.231

6.  TGR5 activation ameliorates hyperglycemia-induced cardiac hypertrophy in H9c2 cells.

Authors:  Kai-Chun Cheng; Wei-Ting Chang; Feng Yu Kuo; Zhih-Cherng Chen; Yingxiao Li; Juei-Tang Cheng
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

Review 7.  Cross-Talk between Gut Microbiota and the Heart: A New Target for the Herbal Medicine Treatment of Heart Failure?

Authors:  Lin Li; Senjie Zhong; Bin Cheng; Hong Qiu; Zhixi Hu
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-06       Impact factor: 2.629

Review 8.  Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure.

Authors:  Qiujin Jia; Hao Li; Huan Zhou; Xiaonan Zhang; Ao Zhang; Yingyu Xie; Yanyang Li; Shichao Lv; Junping Zhang
Journal:  Cardiovasc Ther       Date:  2019-11-16       Impact factor: 3.023

9.  TGR5 Activation Modulates an Inhibitory Effect on Liver Fibrosis Development Mediated by Anagliptin in Diabetic Rats.

Authors:  Daisuke Kaya; Kosuke Kaji; Yuki Tsuji; Satoko Yamashita; Koh Kitagawa; Takahiro Ozutsumi; Yukihisa Fujinaga; Hiroaki Takaya; Hideto Kawaratani; Kei Moriya; Tadashi Namisaki; Takemi Akahane; Hitoshi Yoshiji
Journal:  Cells       Date:  2019-09-26       Impact factor: 6.600

10.  Overexpression of TGR5 alleviates myocardial ischemia/reperfusion injury via AKT/GSK-3β mediated inflammation and mitochondrial pathway.

Authors:  Junzhi Li; Ruining Cheng; Hong Wan
Journal:  Biosci Rep       Date:  2020-01-31       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.